TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 0 | -1 | 1 | 14 | 18 | 37 | 12 |
| P | %wins | 67 | 67 | 67 | 100 | 67 | 100 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/19/12 17:35 | 10/18/12 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Fischer A. Charles | MI | D | P | 42 | 42.49 | 9 | 1 | 50 | 3 | D | 21 | 17 | 11 | -2 | 7 | -1 | 0 | -1 | 2 | 3 | 5 | 12 | 21 | 65 | |
12/28/11 11:03 | 12/23/11 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Fischer A. Charles | MI | D | P | 31 | 30.91 | 12 | 1 | 100 | 2 | D | 27 | -26 | -31 | -6 | -20 | -14 | -10 | -4 | -3 | 0 | 5 | 28 | 48 | 44 | |
8/2/11 18:14 | 8/1/11 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Fischer A. Charles | MI | D | P | 40 | 39.97 | 7 | 1 | New | 1 | D | 106 | 35 | 11 | -4 | -4 | -14 | -14 | 1 | 2 | -6 | -8 | 3 | -14 | 1 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |